Generalized Pustular Psoriasis (GPP) Control is Limited on Traditional Small-molecule Therapy as Measured by the GPP Physician Global Assessment (GPPGA) and Dermatology Life Quality Index (DLQI): Baseline Data from the EFFISAYIL® 2 Trial. J of Skin [Internet]. 2025 Mar. 17 [cited 2025 Jul. 22];9(2):s540. Available from: https://skin.dermsquared.com/skin/article/view/3333